Pain Score Reduction (WOMAC/VAS) | |||||
---|---|---|---|---|---|
Outcome | Number of studies | Pooled SMD (95 CI) | P | Heterogeneity | |
I2 (%) | P | ||||
1 month | 4 | −0.07 [−0.49, 0.35] | 0.74 | 65 | 0.03 |
3 month | 6 | −0.51 [− 0.90, − 0.12] | 0.01 | 72 | 0.003 |
6 month | 7 | −0.78 [− 1.34, − 0.23] | 0.005 | 88 | < 0.00001 |
9 months | 1 | − 1.63 [− 2.14, − 1.12] | < 0.00001 | n/a | n/a |
12 months | 2 | −1.12 [− 3.34, 1.09] | 0.32 | 97 | < 0.00001 |
LP-PRP | 3 | −0.61 [− 0.92, − 0.29] | 0.00002 | 16 | 0.31 |
LR-PRP | 5 | −0.98 [−1.79, − 0.17] | 0.02 | 92 | < 0.00001 |
Single PRP injection | 5 | −0.52 [−1.11, 0.07] | 0.08 | 87 | < 0.00001 |
Triple PRP Injection | 2a | −0.94 [−1.31, − 0.58] | < 0.00001 | 12 | 0.29 |